Bacteriophage MarketThe global bacteriophage market, valued at USD 45.07 million in 2023, is projected to reach USD 68 million by 2033, growing at a CAGR of 4.2% over the forecast period. The ...

Bacteriophage Therapy Market is estimated to be valued at US$ 1,280.9 million in 2023 and is expected to exhibit a CAGR of 3.7% by (2023-2030). BURLINGAME, CA, UNITED STATES, January 17 ...

The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...

Phage therapy is the therapeutic use of bacteriophages to treat bacterial infections. It offers a precise, natural alternative to antibiotics using viruses that specifically target and kill bacteria ...

Bacteriophages, or phages, are viruses that specifically infect bacteria. With the rise of antibiotic-resistant infections, there has been a renewed interest in phage therapy as a potential ...

Returning to Boston this February, the Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Uniting 90+ Chief Executive Officers, Vice Presidents ...

Bacteriophage Therapy Market 2025 Bacteriophage Therapy Market is estimated to be valued at US$ 1,280.9 million in 2023 and is expected to exhibit a CAGR of 3.7% by (2023-2030). BURLINGAME, CA, UNITED ...

The phage therapy market is experiencing significant growth due to the increasing prevalence of antibiotic-resistant infections and the growing interest in alternative treatments. Advances in ...

ShareA university don, Prof. Adeleke Osho, on Thursday, said the misuse of antibiotics and lack of good hygiene can cause the human body to become resistant to antibiotics. According to the Professor ...